We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+2.28%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$38.1B
AUM Growth
Cap. Flow
+$38.4B
Cap. Flow %
100.8%
Top 10 Hldgs %
11.4%
Holding
2,756
New
2,750
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$671M
2
MCD icon
McDonald's
MCD
+$636M
3
TSM icon
TSMC
TSM
+$515M
4
NVO
Novo Nordisk
NVO
+$465M
5
CL icon
Colgate-Palmolive
CL
+$458M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 14.45%
2 Healthcare 11.94%
3 Consumer Discretionary 11.58%
4 Consumer Staples 10.68%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VGZ icon
2301
Vista Gold
VGZ
$245M
$414K ﹤0.01%
+426,600
New +$626K
CTHR
2302
DELISTED
Charles & Colvard Ltd
CTHR
$414K ﹤0.01%
+10,155
New +$413K
RELV
2303
DELISTED
Reliv International Inc
RELV
$413K ﹤0.01%
+46,800
New +$428K
GSOL
2304
DELISTED
Global Sources Ltd
GSOL
$413K ﹤0.01%
+61,508
New +$414K
CMD
2305
DELISTED
Cantel Medical Corporation
CMD
$410K ﹤0.01%
+18,150
New +$393K
SAAS
2306
DELISTED
inContact, Inc.
SAAS
$410K ﹤0.01%
+49,900
New +$389K
NED
2307
DELISTED
NOAH EDUCATION HOLDINGS LTD ADR (CYM)
NED
$410K ﹤0.01%
+277,300
New +$410K
JAKK icon
2308
Jakks Pacific
JAKK
$305M
$408K ﹤0.01%
+3,623
New +$374K
FOLD
2309
DELISTED
Amicus Therapeutics
FOLD
$405K ﹤0.01%
+173,644
New +$534K
CNVS icon
2310
Cineverse
CNVS
$56.4M
$404K ﹤0.01%
+1,422
New +$423K
EGLE
2311
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$404K ﹤0.01%
+43
New +$405K
ATV
2312
DELISTED
Acorn International
ATV
$401K ﹤0.01%
+25,665
New +$395K
NEWS
2313
DELISTED
NewStar Financial, Inc.
NEWS
$401K ﹤0.01%
+30,100
New +$378K
RATE
2314
DELISTED
Bankrate Inc
RATE
$399K ﹤0.01%
+27,800
New +$385K
IIN
2315
DELISTED
IntriCon Corporation
IIN
$398K ﹤0.01%
+113,400
New +$461K
TESO
2316
DELISTED
Tesco Corp
TESO
$398K ﹤0.01%
+30,000
New +$375K
PAR icon
2317
PAR Technology
PAR
$707M
$397K ﹤0.01%
+98,400
New +$406K
WIRE
2318
DELISTED
Encore Wire Corp
WIRE
$397K ﹤0.01%
+11,637
New +$394K
SKY icon
2319
Champion Homes
SKY
$4.58B
$395K ﹤0.01%
+100,600
New +$455K
CME icon
2320
CME Group
CME
$93.5B
$392K ﹤0.01%
+30,000
New +$1.97M
PRSS
2321
DELISTED
CafePress Inc.
PRSS
$392K ﹤0.01%
+62,507
New +$384K
ODFL icon
2322
Old Dominion Freight Line
ODFL
$47.1B
$391K ﹤0.01%
+28,200
New +$378K
HAUP
2323
DELISTED
HAUPPAUGE DIGITAL INC
HAUP
$391K ﹤0.01%
+570,100
New +$491K
CORV
2324
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$390K ﹤0.01%
+199,813
New +$401K
GSB
2325
DELISTED
GlobalSCAPE, Inc.
GSB
$389K ﹤0.01%
+232,700
New +$368K

Similar funds

Renaissance Technologies's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Renaissance Technologies, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.

Its largest position is Eli Lilly: 12,326,205 shares worth $605M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.

  • Renaissance Technologies's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
  • Renaissance Technologies disclosed 2,756 positions in Q2 2013, its first 13F filing on record.

Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.